HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership
"This partnership with Cryoport reflects our dedication to providing patients and clinics with the highest standard of care," said Louis Villalba, TMRW's CEO. "Cryoport's reputation for excellence in reproductive biologistics, paired with TMRW's cutting-edge specimen management technology and safety certifications, delivers unmatched security and peace of mind for transporting specimens in the fertility space."
Revolo Biotherapeutics Shares New Preclinical Data Showcasing the Potential of Sublingual ‘1104 in Allergic Disease
Revolo Biotherapeutics notes additionally, the data continues to demonstrate the differentiated upstream MOA of ‘1104, restoring immune homeostasis by impacting both the effector and regulatory arms of the immune system with a persistence of effect for multiple weeks.
groninger to Highlight Filling and Closing Unit Series for OTC Pharma and Diagnostics Products At Pack Expo
groinger flexcare 101 is part of a broader series of precision filling & closing machines for glass or plastic bottles of various sizes; groninger also will highlight filler-closer for ready-to-use syringes, vials & cartridges.
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research
The automated solution from the BD and Hamilton collaboration standardizes traditionally manual processes and speeds the generation of material for genetic sequencing. The solution includes the newly released BD® OMICS-One XT WTA Assay and the Hamilton® Microlab™ NGS STAR automated liquid handling platform. Because the NGS STAR is already installed in many laboratories and facilities worldwide, more researchers, processing samples across an array of genomics applications, can easily integrate the new automation-ready BD® assay into existing workflows.
New Project Will Enable Rapid Detection of Staphylococcus Bacteria & Create a New Bio-based Disinfectant to Reduce Hospital-acquired Infections
Early detection of nosocomial infections and effective disinfection of hospitals and healthcare centres are key to reducing these figures, but the methods currently used have their limitations. Hence the creation of the NOSOSENS Project, which is working on a new bio-based disinfectant designed to eliminate the main pathogens on a new, flexible and portable biosensor platform. It uses printed electrochemical sensors for rapid, selective detection of Staphylococcus aureus, which is resistant to methicillin and responsible for 11% of nosocomial infections.
At Pack Expo, Schreiner MediPharm Will Showcase New RFID Labels with Digital Seal Function
Also at Pack Expo, Schreiner MediPharm will highlight recently introduced label solutions for applications with sensitive APIs, as well as its latest sustainability-minded product solutions.
Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia
Lyn Rees, Executive Director, Yourgene Health, said: “We are thrilled to support Genetix by enabling them to deliver an advanced prenatal screening solution locally to the pregnant mothers in Colombia. We look forward to a long and fruitful relationship with their pioneering team.
PureTech – Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech’s Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb in March 2024, and unlocks potential future payments related to additional milestones and royalties
Lonza Launches Innovaform™ Accelerator, the New Innovation and Formulation Center in Colmar (FR)
Christian Seufert, President, Capsules & Health Ingredients, Lonza, commented: “The Innovaform™ Innovation and Formulation Accelerator represents a unique solution for drug developers seeking to solve complex dosage form and delivery challenges through innovation.